Skip to Content

Haley Guiliano LLP Operations Continue Uninterrupted During the COVID-19 Pandemic Read More

Practice Areas

USPTO Post-Grant Proceedings

The America Invents Act (AIA) introduced new proceedings by which third-parties may challenge a patent: post-grant review, inter partes review, and covered business method proceedings. Long before the enactment of the AIA, Haley Guiliano’s practitioners represented clients in contested proceedings before the United States Patent and Trademark Office (USPTO), including interferences and inter partes reexamination proceedings. Following enactment of the AIA, our team has continued to represent clients in the various contested proceedings, new and old, at the USPTO in a variety of technical spaces. Our team has the proven technical, legal and procedural expertise in representing clients before the USPTO, whether they are challenging a patent or protecting their own intellectual property.

How we can help:

  • Represent clients — petitioners or patent owners — in post-grant review, inter partes review, and covered business method proceedings and appeals.
  • Help clients stake their claim in interference and derivation proceedings.
  • Help clients strengthen their intellectual property in ex parte re-examination and supplemental examination proceedings.
  • Coordinate post-grant proceedings with clients’ worldwide patent prosecution and litigation strategies.

LET’S CONNECT

Name Required
Email Required

Communication Policy

While we are happy to have you contact us by electronic mail, telephone, surface mail or facsimile transmission, merely communicating with Haley Guiliano LLP or a Haley Guiliano LLP lawyer or employee will not create a lawyer-client relationship. Such a relationship will not arise unless and until the firm agrees with you in writing to handle a particular matter. Importantly, unless and until this has occurred, you should not convey to us any information you regard as personal or confidential, because any such information will not be treated by us as confidential or subject to any confidentiality requirements.